NEWS DETAIL

Fullerton Health Announces the Appointment of David Sin as Group President

Singapore, April 12, 2018 – Fullerton Healthcare Corporation Limited (“Fullerton Health” or the “Group”) today announced that David Sin has been appointed Group President, with effect from 1 March 2018, in addition to his current roles as Co-Founder and Deputy Chairman of Fullerton Health.

As Group President, David will take on an executive role, supporting the existing management team as the company continues to build a strong platform for growth across the region. David will focus on reinforcing infrastructure and operations, overseeing stakeholder management and working closely with the key executive leadership team to further develop the Group’s strategy.

Michael Lim, Chairman of Fullerton Health stated: “Fullerton Health is at an exciting stage of its development, and the appointment of David to Group President greatly supports the company’s growth ambitions. The Board and I are delighted to have such a strong and experienced key executive leadership team to continue building Fullerton Health into the leading healthcare services provider, not just in Singapore, but across Asia. I am confident that we have the right team in place to take Fullerton Health to the next level.”

Dr Michael Tan, Co-Founder and Group CEO of Fullerton Health commented: “I am thrilled to welcome David back to the key executive team at Fullerton Health. David has been integral to the historical success of this company and in building the business together with Dr. Daniel Chan and myself. This new role of Group President will further strengthen our leadership team, and David will continue to work closely alongside us towards achieving our shared vision of bringing affordable, accessible and sustainable healthcare to our patients. In addition, as we seek both organic and inorganic opportunities to expand our service offerings in new and existing markets, David’s extensive financial and deal-making experience will be invaluable.”

David Sin, Co-Founder and Group President of Fullerton Health said: “Having previously served as Executive Chairman of Fullerton Health, I am excited to be re-joining the executive leadership to further support my Co-Founders, Dr. Michael and Dr. Daniel, as we seek to become Asia’s pre-eminent total healthcare services provider. Fullerton Health has made great strides in recent years, and we have an enormous opportunity in front of us to capitalise on our growth, consolidate our presence in existing markets and secure new opportunities for expansion to ensure that everyone has access to affordable healthcare.”